Pharmafile Logo
Pharmafocus logo
Advanced Search

DH admits cancer awareness campaigns failed

June 28, 2012
Sales and Marketing Cancer, Department of Health, GPs, government

The government’s £9 million cancer awareness campaigns were built upon failed pilots, according to newly released data. The national awareness …

News

US judges vote to keep Obamacare

June 28, 2012
Sales and Marketing Health reform, President Obama, US

The US Supreme Court will allow President Obama’s health reforms to stand.The nine-member Supreme Court has decided not to repeal …

News
Yammer image

Microsoft buys Yammer for $1.2 billion

June 28, 2012
Medical Communications Daiichi Sankyo, Facebook, Microsoft, Yammer, social network

Microsoft has acquired Yammer, an internal social networking system for businesses, for $1.2 billion. Set up in 2008, Yammer closely …

News

MRN gets SMART with its clinical trial scheduling

June 28, 2012
Research and Development clinical trials, electronic data capture, medical research network, mrn, patient scheduling

Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial and site nurse support as well …

News
Press release

ZS Associates elects new managing director

June 28, 2012
Business Services, Medical Communications, Sales and Marketing Chris Wright, ZS Associates

Sales and marketing consulting firm ZS Associates announced today that Chris Wright has been elected by firm partners to the …

Appointment

Ireland agrees deal on medicines

June 28, 2012
Business Services, Sales and Marketing AstraZeneca, IPHA, Ireland, Lundbeck, Novartis, pricing

Ireland’s pharmaceutical industry has agreed a deal with the country’s government which breaks a deadlock over prices and access. The …

News
Apps image

Apps not the way forward for trial recruitment

June 28, 2012
Medical Communications Pfizer, apps, digital, virtual trial

After Pfizer admitted defeat in the first ever ‘virtual trial’ earlier this year, it seems that we are not yet …

News
FDA image

FDA clears Arena and Eisai’s obesity drug

June 28, 2012
Sales and Marketing Arena, Belviq, Eisai, FDA, Qnexa, Roche, obesity

Eisai and Arena’s Belviq has gained FDA approval, making it the first obesity drug to be approved in over ten …

News

Astellas submits new prostate cancer drug to EMA

June 28, 2012
Research and Development, Sales and Marketing Astellas, EMA, Medivation, NICE, Zytiga, enzalutamide

Astellas has submitted its investigational prostate cancer drug enzalutamide to the European Medicines Agency. Enzalutamide is a once-daily pill that works …

News
Witty image

Witty warns EU leaders over pricing

June 27, 2012
Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing

Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …

News
ABPI image

ABPI to no longer ‘shy away’ from big issues

June 27, 2012
Medical Communications, Sales and Marketing ABPI, Callaghan, NHS, VBP, Whitehead

The ABPI will actively seek to tackle tough issues like animal testing and clinical trial problems, as it looks to …

News
Tarceva image

NICE final yes for Zytiga and Tarceva

June 27, 2012
Sales and Marketing Janssen, NHS, NICE, NSCLC, Roche, Tarceva, Zytiga

In final guidance published today, NICE is recommending two new drugs for patients with prostate and lung cancer. Janssen’s Zytiga …

News

Amylin withheld safety data, says FDA

June 27, 2012
Research and Development, Sales and Marketing Amylin, Bydureon, Byetta, FDA, lilly

The US medicines regulator says Amylin held back data relating to the safety of its diabetes drug Bydureon. The allegation …

News
CSL Behring

CSL Behring launches new dosing app

June 27, 2012
Medical Communications Beriplex P/N, CSL Behring, app, digital

Biotherapy firm CSL Behring UK has launched an app for doctors to aid the management of its anaesthetic treatment Beriplex …

News

Eisai to enter Russia with epilepsy launch

June 27, 2012
Sales and Marketing Eisai, Russia, Zonegran, emerging markets, epilepsy

Eisai is to enter the Russian market for the first time with the launch of epilepsy drug Zonegran. Entry into the …

News

Roche cuts 1,000 R&D jobs

June 27, 2012
Research and Development, Sales and Marketing AZ, Genentech, Novartis, R&D, Roche, cuts

Roche will make major cuts to its research operations in the US and revamp operations in Europe. Roche will close …

News
Roche image

Roche’s Perjeta increases survival

June 27, 2012
Research and Development, Sales and Marketing EMA, FDA, Herceptin, Perjeta, Roche, breast cancer

Roche’s new drug Perjeta has scored another trial success by increasing overall survival in certain breast cancer patients. The new …

News

London Trust on the brink of going bust

June 26, 2012
Sales and Marketing Lansley, NHS, South London Healthcare, reforms

For the first time in its history an NHS Trust is facing bankruptcy and could be dissolved by the government. …

News
Shire image

Generic approval for Shire’s hyperactivity drug

June 26, 2012
Sales and Marketing ADHD, Adderall XR, FDA, IMS Health, Impax, Shire, Teva

US regulators have delivered a blow to Shire by allowing Actavis Group to produce a generic version of its hyperactivity …

News
Roche image

Roche earmarks $300m for diagnostics HQ

June 26, 2012
Manufacturing and Production Diagnostics, Illumina, Roche, US, manufacturing

Roche has said it intends to invest $300 million over the next 10 years at its diagnostics headquarters in Indianapolis, …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026